Kevin R Oliver

Title: Kevin R Oliver: Innovator in Genetic Research

Introduction

Kevin R Oliver is a notable inventor based in Huntingdon, GB. He has made significant contributions to the field of genetic research, particularly in the development of isolated DNA molecules that have important implications for pharmacology.

Latest Patents

One of his key patents is titled "Isolated DNA molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods." This patent discloses isolated nucleic acid molecules encoding a humanized version of a calcitonin gene-related peptide (CGRP) receptor. The invention includes modifications to the mammalian RAMP1 nucleotide sequence, specifically at amino acid 74, which allows the humanized CGRP receptors to achieve pharmacological profiles similar to the wild type human receptor. Additionally, the patent describes related recombinant vectors, hosts, and methods for generating these humanized CGRP receptors. Non-human transgenic animals expressing humanized RAMP1 are also presented, engineered to provide a CGRP pharmacological profile akin to that of humans.

Career Highlights

Kevin R Oliver is associated with Merck & Co., Inc., where he continues to advance his research in genetic engineering and pharmacology. His work has been instrumental in developing innovative solutions that bridge the gap between genetic research and practical applications in medicine.

Collaborations

He has collaborated with notable colleagues such as Stefanie A Kane and Christopher A Salvatore, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Kevin R Oliver's contributions to genetic research and his innovative patent on humanized CGRP receptors highlight his role as a leading inventor in the field. His work not only advances scientific understanding but also paves the way for future medical applications.